Étienne Dardenne

N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

Étienne Dardenne, Himisha Beltran, Matteo Benelli et al. · Cancer Cell · 2016 · 565 citations · Full text

Medicine, Molecular Biology, Oncology +10

A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers

Himisha Beltran, Clara Oromendia, Daniel C. Danila et al. · Clinical Cancer Research · 2018 · 275 citations · Full text

Medicine, Pharmacology, Urology +17

RNA Helicases DDX5 and DDX17 Dynamically Orchestrate Transcription, miRNA, and Splicing Programs in Cell Differentiation

Étienne Dardenne, Micaela Polay Espinoza, Laurent Fattet et al. · Cell Reports · 2014 · 233 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +16

Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

Loredana Puca, Katie Gavyert, Verena Sailer et al. · Science Translational Medicine · 2019 · 209 citations · Full text

Medicine, Oncology, Pharmacology +17

N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer

Adeline Berger, Nicholas J. Brady, Rohan Bareja et al. · Journal of Clinical Investigation · 2019 · 197 citations · Full text

Medicine, Genetics, Oncology +17